159 related articles for article (PubMed ID: 37037766)
1. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
Wang YY; Dong K; Wang K; Sun Y; Xing BC
Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
[TBL] [Abstract][Full Text] [Related]
2. A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion.
Lu L; Wei W; Huang C; Li S; Zhong C; Wang J; Yu W; Zhang Y; Chen M; Ling Y; Guo R
Hepatol Int; 2021 Jun; 15(3):651-662. PubMed ID: 33835379
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
4. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.
Chen ZY; Guo ZX; Lu LH; Mei J; Lin WP; Li SH; Wei W; Guo RP
Cancer Med; 2021 Aug; 10(16):5466-5474. PubMed ID: 34212527
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.
Guan R; Lin W; Zou J; Mei J; Wen Y; Lu L; Guo R
Cancer Control; 2022; 29():10732748221102820. PubMed ID: 35609265
[TBL] [Abstract][Full Text] [Related]
7. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract][Full Text] [Related]
9. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Wang X; Wang Z; Wu L
BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
[TBL] [Abstract][Full Text] [Related]
10. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.
Xiong SP; Wang CH; Zhang MF; Yang X; Yun JP; Liu LL
J Transl Med; 2024 May; 22(1):472. PubMed ID: 38762511
[TBL] [Abstract][Full Text] [Related]
11. Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).
Bell R; Pandanaboyana S; Lodge JPA; Prasad KR; Jones R; Hidalgo E
Langenbecks Arch Surg; 2017 Jun; 402(4):575-583. PubMed ID: 27456677
[TBL] [Abstract][Full Text] [Related]
12. The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density.
Huang CW; Lin SE; Huang SF; Yu MC; Tang JH; Tsai CN; Hsu HY
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358846
[TBL] [Abstract][Full Text] [Related]
13. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
[TBL] [Abstract][Full Text] [Related]
14. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
[TBL] [Abstract][Full Text] [Related]
15. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant portal hypertension (CSPH) on early-stage HCC following hepatectomy: What's the impact?
Xia F; Huang Z; Zhang Q; Ndhlovu E; Chen X; Zhang B; Zhu P
Eur J Surg Oncol; 2023 Apr; 49(4):771-779. PubMed ID: 36372619
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
19. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]